- 专利标题： MODIFIED NK-92 CELLS FOR TREATING CANCER
-
申请号： EP24185893.5申请日： 2016-06-10
-
公开(公告)号： EP4424326A2公开(公告)日： 2024-09-04
- 发明人: LEE, Tien
- 申请人： ImmunityBio, Inc.
- 申请人地址： US Culver City, CA 90232 9920 Jefferson Boulevard
- 专利权人： ImmunityBio, Inc.
- 当前专利权人： ImmunityBio, Inc.
- 当前专利权人地址： US Culver City, CA 90232 9920 Jefferson Boulevard
- 代理机构： Elkington and Fife LLP
- 优先权： US 1562173701P 2015.06.10
- 分案原申请号： 23176181.8 2023.05.30;16808427.5 2016.06.10
- 主分类号： A61K39/395
- IPC分类号： A61K39/395
摘要：
Provided herein are NK-92 cells expressing at least one CAR and at least one Fc receptor. Also provided are methods of treatment of a patient having or suspected of having a disease that is treatable with NK-92 cells, such as cancer, comprising administering to the patient NK-92-Fc-CAR.
公开/授权文献
- EP4424326A3 MODIFIED NK-92 CELLS FOR TREATING CANCER 公开/授权日：2024-11-13
信息查询
